- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 831907, 7 pages
Prognostic Significance of Immunohistochemical Phenotypes in Patients Treated for High-Grade Cervical Intraepithelial Neoplasia
1Department of Gynecology & Obstetrics, Vita-Salute San Raffaele University, School of Medicine at San Raffaele Scientific Institute, Via Olgettina 58, 20132 Milan, Italy
2Department of Pathology, Vita-Salute San Raffaele University, School of Medicine at San Raffaele Scientific Institute, Via Olgettina 58, 20132 Milan, Italy
Received 21 April 2013; Revised 2 October 2013; Accepted 4 October 2013
Academic Editor: Martin Bornhaeuser
Copyright © 2013 Massimo Origoni et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- I. Soerjomataram, J. Lortet-Tieulent, D. M. Parkin et al., “Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions,” The Lancet, vol. 380, no. 9856, pp. 1840–1850, 2012.
- H. zur Hausen, “Papillomaviruses and cancer: from basic studies to clinical application,” Nature Reviews Cancer, vol. 2, no. 5, pp. 342–350, 2002.
- F. X. Bosch, M. M. Manos, N. Munoz et al., “Prevalence of human papillomavirus in cervical cancer: a worldwide perspective,” Journal of the National Cancer Institute, vol. 87, no. 11, pp. 796–802, 1995.
- M. Schiffman and N. Wentzensen, “Human Papillomavirus infection and the multistage carcinogenesis of cervical cancer,” Cancer Epidemiology, Biomarkers & Prevention, vol. 22, no. 4, pp. 553–560, 2013.
- M. Evander, K. Edlund, A. Gustafsson et al., “Human papillomavirus infection is transient in young women: a population- based cohort study,” Journal of Infectious Diseases, vol. 171, no. 4, pp. 1026–1030, 1995.
- G. Y. F. Ho, R. Bierman, L. Beardsley, C. J. Chang, and R. D. Burk, “Natural history of cervicovaginal papillomavirus infection in young women,” The New England Journal of Medicine, vol. 338, no. 7, pp. 423–428, 1998.
- M. Schiffman, P. E. Castle, J. Jeronimo, A. C. Rodriguez, and S. Wacholder, “Human papillomavirus and cervical cancer,” The Lancet, vol. 370, no. 9590, pp. 890–907, 2007.
- R. W. Tindle, “Immune evasion in human papillomavirus-associated cervical cancer,” Nature Reviews Cancer, vol. 2, no. 1, pp. 59–65, 2002.
- M. H. Hibma, “The immune response to Papillomavirus during infection persistence and regression,” The Open Virology Journal, vol. 6, supplement 2, pp. 241–248, 2012.
- T. Sasagawa, H. Takagi S, and S. Makinoda, “Immune responses against Human Papillomavirus (HPV) infection and evasion of host defense on cervical cancer,” Journal of Infection and Chemotherapy, vol. 18, no. 6, pp. 807–815, 2012.
- K. U. Petry, D. Scheffel, U. Bode et al., “Cellular immunodeficiency enhances the progression of human papillomavirus-associated cervical lesions,” International Journal of Cancer, vol. 57, no. 6, pp. 836–840, 1994.
- D. Serraino, P. Carrieri, C. Pradier, et al., “Risk of invasive cervical cancer among women with, or at risk for, HIV infection,” International Journal of Cancer, vol. 82, no. 3, pp. 334–337, 1999.
- M. I. Alloub, B. B. B. Barr, K. M. McLaren, I. W. Smith, W. H. Bunney, and G. E. Smart, “Human papillomavirus infection and cervical intraepithelial neoplasia in women with renal allografts,” British Medical Journal, vol. 298, no. 6667, pp. 153–156, 1989.
- F. B. Lillo, D. Ferrari, F. Veglia et al., “Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy,” Journal of Infectious Diseases, vol. 184, no. 5, pp. 547–551, 2001.
- C. Uberti-Foppa, M. Origoni, M. Maillard et al., “Evaluation of the detection of human papillomavirus genotypes in cervical specimens by hybrid capture as screening for precancerous lesions in HIV-positive women,” Journal of Medical Virology, vol. 56, no. 2, pp. 133–137, 1998.
- C. K. Fairley, S. Chen, S. N. Tabrizi et al., “Prevalence of HPV DNA in cervical specimens in women with renal transplants: a comparison with dialysis-dependent patients and patients with renal impairment,” Nephrology Dialysis Transplantation, vol. 9, no. 4, pp. 416–420, 1994.
- A. Carus, M. Ladekarl, B. S. Nedergaard, and F. Donskov, “Tumour-associated CD66b+ neutrophil count is an independent prognostic factor for recurrence in localized cervical cancer,” British Journal of Cancer, vol. 108, pp. 2116–2122, 2013.
- P. J. de Vos van Steenwijk, T. H. Ramwadhdoebe, R. Goedemans et al., “Tumor-infiltrating CD14-positive myeloid cells and CD8-positive T-cells prolong survival in patients with cervical carcinoma,” International Journal of Cancer, vol. 133, no. 12, pp. 2884–2894, 2013.
- S. J. Piersma, E. S. Jordanova, M. I. E. van Poelgeest et al., “High number of intraepithelial CD8+ tumor-infiltrating lymphocytes is associated with the absence of lymph node metastases in patients with large early-stage cervical cancer,” Cancer Research, vol. 67, no. 1, pp. 354–361, 2007.
- J. Konya and J. Dillner, “Immunity to oncogenic human papillomaviruses,” Advances in Cancer Research, vol. 82, pp. 205–238, 2001.
- M. Evans, L. K. Borysiewicz, A. S. Evans et al., “Antigen processing defects in cervical carcinomas limit the presentation of a CTL epitope from human papillomavirus 16 E6,” Journal of Immunology, vol. 167, no. 9, pp. 5420–5428, 2001.
- S. L. Giannini, P. Hubert, J. Doyen, J. Boniver, and P. Delvenne, “Influence of the mucosal epithelium microenvironment on Langerhans cells: implications for the development of squamous intraepithelial lesions of the cervix,” International Journal of Cancer, vol. 97, no. 5, pp. 654–659, 2002.
- A. Manickam, M. Sivanandham, and I. L. Tourkova, “Immunological role of dendritic cells in cervical cancer,” Advances in Experimental Medicine and Biology, vol. 601, pp. 155–162, 2007.
- S.-J. Um, J.-W. Rhyu, E.-J. Kim, K.-C. Jeon, E.-S. Hwang, and J.-S. Park, “Abrogation of IRF-1 response by high-risk HPV E7 protein in vivo,” Cancer Letters, vol. 179, no. 2, pp. 205–212, 2002.
- S. Monnier-Benoit, F. Mauny, D. Riethmuller et al., “Immunohistochemical analysis of CD4+ and CD8+ T-cell subsets in high risk human papillomavirus-associated pre-malignant and malignant lesions of the uterine cervix,” Gynecologic Oncology, vol. 102, no. 1, pp. 22–31, 2006.
- H. J. Bontkes, T. D. de Gruijl, and A. I. C. van der Muysemberg, “Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes in women with cervical neoplasia,” International Journal of Cancer, vol. 88, no. 1, pp. 92–98, 2000.
- A. de Jong, S. H. van der Burg, K. M. C. Kwappenberg et al., “Frequent detection of human papillomavirus 16 E2-specific T-helper immunity in healthy subjects,” Cancer Research, vol. 62, no. 2, pp. 472–479, 2002.
- N. Coleman, H. D. L. Birley, A. M. Renton et al., “Immunological events in regressing genital warts,” American Journal of Clinical Pathology, vol. 102, no. 6, pp. 768–774, 1994.
- K. Hong, C. E. Greer, N. Ketter, G. van Nest, and X. Paliard, “Isolation and characterization of human papillomavirus type 6-specific T cells infiltrating genital warts,” Journal of Virology, vol. 71, no. 9, pp. 6427–6432, 1997.
- M. Origoni, P. Cristoforoni, S. Costa, L. Mariani, P. Scirpa, and A. Lorincz M, “HPV-DNA testing for cervical cancer precursors: from evidence to clinical practice,” Ecancermedicalscience, vol. 6, article 258, 2012.
- L. Mariani, M. Sideri, S. Costa, P. Cristoforoni, M. Origoni, and M. Preti, “Human papillomavirus DNA and Pap tests: the need for cotesting in opportunistic setting during the transition time,” Journal of Lower Genital Tract Disease, vol. 17, no. 3, pp. 362–365, 2013.
- M. Origoni, G. Carminati, S. Rolla et al., “Human papillomavirus viral load expressed as Relative Light Units (RLU) correlates with the presence and grade of preneoplastic lesions of the uterine cervix in Atypical Squamous Cells of Undetermined Significance (ASCUS) cytology,” European Journal of Clinical Microbiology and Infectious Diseases, vol. 31, no. 9, pp. 2401–2406, 2012.
- M. Origoni, G. Carminati, M. Sideri, M. Clementi, S. Rolla, and M. Candiani, “‘Low-grade positivity’ of HPV viral load after Atypical Squamous Cells of Undetermined Significance (ASC-US) cytology identifies women at low-risk for cervical intraepithelial neoplasia grade 2 and 3,” European Journal of Gynaecological Oncology, vol. 33, no. 3, pp. 261–264, 2012.
- M. Origoni, “High viral load identifies cervical lesions—letter,” Cancer Epidemiology Biomarkers & Prevention, vol. 22, no. 10, article 1924, 2013.
- J. M. M. Walboomers, M. V. Jacobs, M. M. Manos et al., “Human papillomavirus is a necessary cause of invasive cervical cancer worldwide,” Journal of Pathology, vol. 189, pp. 12–19, 1999.
- A.-B. Moscicki, M. Schiffman, S. Kjaer, and L. L. Villa, “Chapter 5: updating the natural history of HPV and anogenital cancer,” Vaccine, vol. 24, no. 3, pp. S42–S51, 2006.
- D. M. Parkin and F. Bray, “Chapter 2: the burden of HPV-related cancers,” Vaccine, vol. 24, no. 3, pp. S11–S25, 2006.
- M. Y. Tjiong, T. A. Out, J. Ter Schegget, M. P. M. Burger, and N. Van der Vange, “Epidemiologic and mucosal immunologic aspects of HPV infection and HPV-related cervical neoplasia in the lower female genital tract: a review,” International Journal of Gynecological Cancer, vol. 11, no. 1, pp. 9–17, 2001.
- A. Ferenczy, F. Coutlée, E. Franco, and C. Hankins, “Human papillomavirus and HIV coinfection and the risk of neoplasias of the lower genital tract: a review of recent developments,” Canadian Medical Association Journal, vol. 169, no. 5, pp. 431–434, 2003.
- M. Origoni, C. Stefani, G. Dell'Antonio, G. Carminati, M. Parma, and M. Candiani, “Cervical human Papillomavirus in transplanted Italian women: a long-term prospective follow-up study,” Journal of Clinical Virology, vol. 51, no. 4, pp. 250–254, 2011.
- D. H. Schuurhuis, N. Fu, F. Ossendorp, and C. J. M. Melief, “Ins and outs of dendritic cells,” International Archives of Allergy and Immunology, vol. 140, no. 1, pp. 53–72, 2006.
- J. Banchereau, F. Briere, C. Caux et al., “Immunobiology of dendritic cells,” Annual Review of Immunology, vol. 18, pp. 767–811, 2000.
- S. C. Fausch, D. M. Da Silva, M. P. Rudolf, and W. M. Kast, “Human papillomavirus virus-like particles do not activate Langerhans cells: a possible immune escape mechanism used by human papillomaviruses,” Journal of Immunology, vol. 169, no. 6, pp. 3242–3249, 2002.
- I. C. Le Poole, W. M. ElMasri, C. J. Denman et al., “Langerhans cells and dendritic cells are cytotoxic towards HPV16 E6 and E7 expressing target cells,” Cancer Immunology, Immunotherapy, vol. 57, no. 6, pp. 789–797, 2008.
- A. de Jong, M. I. E. van Poelgeest, J. M. Van der Hulst et al., “Human papillomavirus type 16-positive cervical cancer is associated with impaired CD4+ T-cell immunity against early antigens E2 and E6,” Cancer Research, vol. 64, no. 15, pp. 5449–5455, 2004.
- D. E. Warrino, W. C. Olson, W. T. Knapp et al., “Disease-stage variance in functional CD4+ T-cell responses against novel pan-human leukocyte antigen-D region presented human papillomavirus-16 E7 epitopes,” Clinical Cancer Research, vol. 10, no. 10, pp. 3301–3308, 2004.
- S. Seresini, M. Origoni, F. Lillo et al., “IFN-γ produced by human papilloma virus-18 E6-specific CD4+ T cells predicts the clinical outcome after surgery in patients with high-grade cervical lesions,” Journal of Immunology, vol. 179, no. 10, pp. 7176–7183, 2007.
- R. D. M. Steenbergen, V. E. OudeEngberink, D. Kramer et al., “Down-regulation of GATA-3 expression during human papillomavirus-mediated immortalization and cervical carcinogenesis,” American Journal of Pathology, vol. 160, no. 6, pp. 1945–1951, 2002.